PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Consolidated Net Profit | ₹18 Cr | ₹-186 Cr | ₹376 Cr | ₹835 Cr |
What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹-186 Cr |
Mar2022 | ₹376 Cr |
Mar2021 | ₹835 Cr |
How is Consolidated Net Profit of PIRAMAL PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | Positive | |
Mar2023 | ₹-186 Cr | Negative | |
Mar2022 | ₹376 Cr | -54.98 | |
Mar2021 | ₹835 Cr | - |
Compare Consolidated Net Profit of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹28,039.5 Cr | 3.6% | 1.5% | 42.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,519.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,903.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
CIPLA | ₹121,669.0 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,097.0 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,605.0 Cr | 1.4% | 1.3% | 17% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 3.6% |
1.5% |
42.7% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses